Peijia Medical Limited

Equities

9996

KYG6981F1090

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. Other stock markets 22:49:31 2024-07-04 EDT			5-day change	1st Jan Change
2.42 ^HKD	+2.54%		+6.14%	-67.25%

06-23	Peijia Medical Limited commences an Equity Buyback Plan for 67,885,680 shares, representing 10% of its issued share capital, under the authorization approved on May 25, 2023.	CI
06-20	Peijia Medical Launches Share Buyback Plan	MT

Peijia Medical Limited Announces Unaudited Group Revenue Results for the Year Ended December 31, 2021

January 26, 2022 at 05:05 pm

Peijia Medical Limited announced unaudited group revenue results for the year ended December 31, 2021. For the period, the company reported group revenue of RMB 136.5 million compared to RMB 38.7 million a year ago.

Latest news about Peijia Medical Limited

Peijia Medical Limited commences an Equity Buyback Plan for 67,885,680 shares, representing 10% of its issued share capital, under the authorization approved on May 25, 2023.	06-23	CI
Peijia Medical Launches Share Buyback Plan	06-20	MT
JenaValve Technology, Inc. announced that it has received $100.399994 million in funding from a group of investors	04-07	CI
Peijia Medical Limited Delays in Publication of 2023 Annual Results	04-01	CI
Peijia Medical Narrows 2023 Loss as Revenue Jumps 76%	04-01	MT
Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio Transcatheter Aortic Regurgitation Clinical Trial	01-29	CI
Peijia Medical's 2023 Profit to Jump Up to 79.4%	01-26	MT
Peijia Medical Limited Announces Unaudited Revenue Results for the Year Ended December 31, 2023	01-25	CI
Peijia Medical's Stock Jumps on Positive Updates For Two Devices	23-10-27	MT
Peijia Medical Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Peijia Medical Enrolls First Patient in TaurusTrio Transcatheter System; Shares Up 4%	23-08-01	MT
Peijia Medical Limited Announces First Patient in Multi-Center Registration Clinical Trial of Taurustrio?? Transcatheter Aortic Valve Replacement System in China	23-07-31	CI
Peijia Medical's H1 Revenue Rises By Up to 94%	23-07-21	MT
Peijia Medical Limited Provides Unaudited Revenue Guidance for the Period from January 1, 2023 to June 30, 2023	23-07-21	CI
China Approves Peijia Medical Unit's Micro Guidewire for Neuro-Intervention Operations	23-07-06	MT
Peijia Medical Limited Receives Approval from the National Medical Products Administration of the PRC for the Registration Application of DCwireTM Micro Guidewire	23-07-06	CI
Peijia Medical Completes Two Commercial Implants with Trilogy System in Hong Kong	23-05-15	MT
Peijia Medical's 2022 Loss Narrows 29%	23-04-03	MT
Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Peijia Medical's 2022 Revenue Surges Up to 90.4%	23-01-17	MT
Peijia Medical Limited Reports Unaudited Operating Statistics for the Year Ended December 31, 2022	23-01-17	CI
Peijia Medical Enrolls First Patient in Transcatheter Repair System Clinical Trial in China	22-12-04	MT
Peijia Medical Limited Announces First Patient Enrollment in the Multi-Center Registration Clinical Trial of Geminione Transcatheter Edge-To-Edge Repair System in China	22-12-04	CI
Peijia Medical Completes First Patient Implant in Transcatheter Tricuspid Valve Replacement System Trial	22-11-24	MT

Chart Peijia Medical Limited

Duration

Period

More charts

Company Profile

Peijia Medical Ltd is a China-based holding company mainly engaged in the research and development of interventional procedural medical devices. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The Company's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The Company operates its businesses primarily in domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Peijia Medical Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.197 CNY

Average target price

9.924 CNY

Spread / Average Target

+351.68%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
PEIJIA MEDICAL LIMITED	-67.25%	207M
STRYKER CORPORATION	+10.87%	126B
SMITH & NEPHEW PLC	-2.27%	10.98B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-23.89%	6.87B
GLAUKOS CORPORATION	+50.07%	6.51B
INSPIRE MEDICAL SYSTEMS, INC.	-34.16%	3.98B
AXONICS, INC.	+8.50%	3.44B
ENOVIS CORPORATION	-20.67%	2.44B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-19.65%	1.88B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-23.49%	1.72B

Medical Devices & Implants